A 50-year-old female patient with a 15-year history of epilepsy was admitted to our hospital due to generalized convulsive status epilepticus. The patient was initially hospitalized in the Intensive Care Unit and then in the Department of Neurology. The repeated magnetic resonance imaging of the head was normal, as well as the results of extensive diagnostics for infectious causes. Cerebrospinal fluid (CSF) examination showed an increased protein level and slightly elevated cytosis with lymphocyte predominance. Antinuclear antibodies ANA Hep-2 were detected in serum in titer > 1:2560 (speckled type of immunofluorescence) without specificity in the immunoblot testing. Due to the appearance of psychotic symptoms, diseases, and central nervous system (CNS) involvement may occur in the disease course [1, 2] . After histopathological evaluation of labial salivary glands, where typical lymphocytic infiltrates were present (Fig.1B) , the patient was diagnosed with pSS (ACR/EULAR criteria from 2016 were fulfilled) [3] . Lumbar puncture was performed to assess whether neuropsychiatric symptoms may result from CNS involvement in the course of pSS. In the meantime patient's condition has deteriorated -tremor of the limbs, anxiety, speech articulation problems and disorientation were observed. The CSF results showed the presence of few lymphocytes in the field of view, increased concentration of protein and albumin, presence of oligoclonal IgG bands (type IV according to Charcot classification) and presence of antinuclear antibodies with immunofluorescence pattern similar to that found in serum ( Fig.1C) . Based on the overall clinical picture the patient was diagnosed with CNS involvement in the course of pSS. Improvement of general condition and complete resolution of neuropsychiatric symptoms have been observed after immunosuppressive treatment with intravenous metyprednisolone pulses (5x500mg), followed by oral prednisone 1 mg/kg and intravenous cyclophosphamide infusions (15mg/kg once a month for six months). This case, along with other reports [4] , points the need for an interdisciplinary approach to rheumatic diseases. 
